Regression of mature lymphatic vessels in the cornea by photodynamic therapy.

Author: BiY, BockF, BucherF, CursiefenC, GehlsenU, HosD

Paper Details 
Original Abstract of the Article :
Corneal (lymph) angiogenesis is a predominant risk-factor for immune rejection after transplantation. Techniques to regress pre-existing pathological corneal lymphatic vessels prior to transplantation are missing so far. Therefore we analysed the possibility to regress corneal lymphatic vessels by p...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1136/bjophthalmol-2013-303887

データ提供:米国国立医学図書館(NLM)

Photodynamic Therapy: A Light-Based Approach to Regressing Corneal Lymphatic Vessels

The field of [ophthalmology] is constantly searching for new ways to prevent [immune rejection] after corneal transplantation. This study investigates the potential of [photodynamic therapy (PDT)] in regressing [pre-existing corneal lymphatic vessels]. Researchers injected [verteporfin intrastromally] and applied PDT to the corneas of study subjects. They found that [PDT effectively regressed mature lymphatic vessels] in the cornea. The study highlighted [the potential of PDT as a pre-transplantation treatment] for preventing immune rejection.

A New Tool for Preventing Corneal Transplant Rejection

This research suggests that [PDT] could be a valuable tool for preventing immune rejection after corneal transplantation. The study's findings demonstrate [the effectiveness of PDT in regressing pre-existing corneal lymphatic vessels].

Shining a Light on Corneal Transplant Rejection

Corneal transplant rejection is a complex challenge. This study shines a light on a new approach to prevention, demonstrating [the potential of PDT to reduce the risk of rejection].

Dr. Camel's Conclusion

This study highlights the potential of photodynamic therapy as a powerful tool for preventing corneal transplant rejection. The researchers have discovered a new light in the desert of transplantation, offering a beacon of hope for patients seeking a better outcome.

Date :
  1. Date Completed 2014-04-10
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

24414403

DOI: Digital Object Identifier

10.1136/bjophthalmol-2013-303887

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.